These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


495 related items for PubMed ID: 23690394

  • 1. Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy.
    Valente AM, Lakdawala NK, Powell AJ, Evans SP, Cirino AL, Orav EJ, MacRae CA, Colan SD, Ho CY.
    Circ Cardiovasc Genet; 2013 Jun; 6(3):230-7. PubMed ID: 23690394
    [Abstract] [Full Text] [Related]

  • 2. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Ho CY, Abbasi SA, Neilan TG, Shah RV, Chen Y, Heydari B, Cirino AL, Lakdawala NK, Orav EJ, González A, López B, Díez J, Jerosch-Herold M, Kwong RY.
    Circ Cardiovasc Imaging; 2013 May 01; 6(3):415-22. PubMed ID: 23549607
    [Abstract] [Full Text] [Related]

  • 3. Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Farhad H, Seidelmann SB, Vigneault D, Abbasi SA, Yang E, Day SM, Colan SD, Russell MW, Towbin J, Sherrid MV, Canter CE, Shi L, Jerosch-Herold M, Bluemke DA, Ho C, Neilan TG.
    J Cardiovasc Magn Reson; 2017 Dec 28; 19(1):107. PubMed ID: 29284499
    [Abstract] [Full Text] [Related]

  • 4. Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy.
    Lakdawala NK, Thune JJ, Maron BJ, Cirino AL, Havndrup O, Bundgaard H, Christiansen M, Carlsen CM, Dorval JF, Kwong RY, Colan SD, Køber LV, Ho CY.
    Am J Cardiol; 2011 Dec 01; 108(11):1606-13. PubMed ID: 21943931
    [Abstract] [Full Text] [Related]

  • 5. The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study.
    Ho CY, Day SM, Colan SD, Russell MW, Towbin JA, Sherrid MV, Canter CE, Jefferies JL, Murphy AM, Cirino AL, Abraham TP, Taylor M, Mestroni L, Bluemke DA, Jarolim P, Shi L, Sleeper LA, Seidman CE, Orav EJ, HCMNet Investigators.
    JAMA Cardiol; 2017 Apr 01; 2(4):419-428. PubMed ID: 28241245
    [Abstract] [Full Text] [Related]

  • 6. Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers.
    Hughes RK, Camaioni C, Augusto JB, Knott K, Quinn E, Captur G, Seraphim A, Joy G, Syrris P, Elliott PM, Mohiddin S, Kellman P, Xue H, Lopes LR, Moon JC.
    J Am Heart Assoc; 2021 Aug 03; 10(15):e020227. PubMed ID: 34310159
    [Abstract] [Full Text] [Related]

  • 7. Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression.
    Ho CY, Lakdawala NK, Cirino AL, Lipshultz SE, Sparks E, Abbasi SA, Kwong RY, Antman EM, Semsarian C, González A, López B, Diez J, Orav EJ, Colan SD, Seidman CE.
    JACC Heart Fail; 2015 Feb 03; 3(2):180-8. PubMed ID: 25543971
    [Abstract] [Full Text] [Related]

  • 8. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography.
    Corona-Villalobos CP, Sorensen LL, Pozios I, Chu L, Eng J, Abraham MR, Abraham TP, Kamel IR, Zimmerman SL.
    Int J Cardiovasc Imaging; 2016 Jun 03; 32(6):945-54. PubMed ID: 26896038
    [Abstract] [Full Text] [Related]

  • 9. Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation.
    Sipola P, Magga J, Husso M, Jääskeläinen P, Peuhkurinen K, Kuusisto J.
    Eur Radiol; 2011 Jul 03; 21(7):1383-9. PubMed ID: 21274714
    [Abstract] [Full Text] [Related]

  • 10. Abnormal cardiac formation in hypertrophic cardiomyopathy: fractal analysis of trabeculae and preclinical gene expression.
    Captur G, Lopes LR, Patel V, Li C, Bassett P, Syrris P, Sado DM, Maestrini V, Mohun TJ, McKenna WJ, Muthurangu V, Elliott PM, Moon JC.
    Circ Cardiovasc Genet; 2014 Jun 03; 7(3):241-8. PubMed ID: 24704860
    [Abstract] [Full Text] [Related]

  • 11. Assessment of myocardial oxygenation, strain, and diastology in MYBPC3-related hypertrophic cardiomyopathy: a cardiovascular magnetic resonance and echocardiography study.
    Grover S, Lloyd R, Perry R, Lou PW, Haan E, Yeates L, Woodman R, Atherton JJ, Semsarian C, Selvanayagam JB.
    Eur Heart J Cardiovasc Imaging; 2019 Aug 01; 20(8):932-938. PubMed ID: 30668650
    [Abstract] [Full Text] [Related]

  • 12. Echocardiographic Strain Abnormalities Precede Left Ventricular Hypertrophy Development in Hypertrophic Cardiomyopathy Mutation Carriers.
    Canciello G, Lombardi R, Borrelli F, Ordine L, Chen SN, Santoro C, Frisso G, di Napoli S, Polizzi R, Cristiano S, Esposito G, Losi MA.
    Int J Mol Sci; 2024 Jul 25; 25(15):. PubMed ID: 39125703
    [Abstract] [Full Text] [Related]

  • 13. CMR derived left ventricular septal convexity in carriers of the hypertrophic cardiomyopathy-causing MYBPC3-Q1061X mutation.
    Tarkiainen M, Sipola P, Jalanko M, Heliö T, Jääskeläinen P, Kivelä K, Laine M, Lauerma K, Kuusisto J.
    Sci Rep; 2019 Apr 11; 9(1):5960. PubMed ID: 30976029
    [Abstract] [Full Text] [Related]

  • 14. Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy.
    Ho CY, Carlsen C, Thune JJ, Havndrup O, Bundgaard H, Farrohi F, Rivero J, Cirino AL, Andersen PS, Christiansen M, Maron BJ, Orav EJ, Køber L.
    Circ Cardiovasc Genet; 2009 Aug 11; 2(4):314-21. PubMed ID: 20031602
    [Abstract] [Full Text] [Related]

  • 15. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
    Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I, Biller L, Lesser JR, Udelson JE, Manning WJ, Appelbaum E.
    J Am Coll Cardiol; 2009 Jul 14; 54(3):220-8. PubMed ID: 19589434
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular magnetic resonance of mitral valve length in hypertrophic cardiomyopathy.
    Tarkiainen M, Sipola P, Jalanko M, Heliö T, Laine M, Järvinen V, Häyrinen K, Lauerma K, Kuusisto J.
    J Cardiovasc Magn Reson; 2016 Jun 04; 18(1):33. PubMed ID: 27259862
    [Abstract] [Full Text] [Related]

  • 17. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
    Hiremath P, Lawler PR, Ho JE, Correia AW, Abbasi SA, Kwong RY, Jerosch-Herold M, Ho CY, Cheng S.
    Circ Heart Fail; 2016 Sep 04; 9(9):. PubMed ID: 27623770
    [Abstract] [Full Text] [Related]

  • 18. Electrophysiological Characterization of Subclinical and Overt Hypertrophic Cardiomyopathy by Magnetic Resonance Imaging-Guided Electrocardiography.
    Joy G, Lopes LR, Webber M, Ardissino AM, Wilson J, Chan F, Pierce I, Hughes RK, Moschonas K, Shiwani H, Jamieson R, Velazquez PP, Vijayakumar R, Dall'Armellina E, Macfarlane PW, Manisty C, Kellman P, Davies RH, Tome M, Koncar V, Tao X, Guger C, Rudy Y, Hughes AD, Lambiase PD, Moon JC, Orini M, Captur G.
    J Am Coll Cardiol; 2024 Mar 19; 83(11):1042-1055. PubMed ID: 38385929
    [Abstract] [Full Text] [Related]

  • 19. Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking.
    Vigneault DM, Yang E, Jensen PJ, Tee MW, Farhad H, Chu L, Noble JA, Day SM, Colan SD, Russell MW, Towbin J, Sherrid MV, Canter CE, Shi L, Ho CY, Bluemke DA.
    Radiology; 2019 Mar 19; 290(3):640-648. PubMed ID: 30561279
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations.
    Pöyhönen P, Hiippala A, Ollila L, Kaasalainen T, Hänninen H, Heliö T, Tallila J, Vasilescu C, Kivistö S, Ojala T, Holmström M.
    J Cardiovasc Magn Reson; 2015 Oct 24; 17():89. PubMed ID: 26496977
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.